ZIRCON Phase III Kidney Cancer Imaging Study Completes Enrolment

Go back to ZIRCON Phase III Kidney Cancer Imaging Study Completes Enrolment
TRANS-LUX CORPORATION (NASDAQ: TLX) Delayed: 9.45 +0.01 (0.11%)
Previous Close $9.44    52 Week High $2.18 
Open $9.42    52 Week Low $0.30 
Day High $9.55    P/E N/A 
Day Low $9.34    EPS $-3.32 
Volume 330,358